168 related articles for article (PubMed ID: 29774886)
1. [Evaluation of inflammatory activity in thyroid associated ophthalmopathy by SPECT/CT with 99mTc-DTPA].
Liu D; Xu X; Wen D; Tan J; Jiang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 43(4):457-460. PubMed ID: 29774886
[TBL] [Abstract][Full Text] [Related]
2. [The application of
Tang MT; Zeng XY; Li Y; Sun HT; Liu SY; Yuan X; Lu W
Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):830-836. PubMed ID: 34743468
[No Abstract] [Full Text] [Related]
3. [Nontarget area and threshold selection in 99mTc-DTPA orbital SPECT/CT imaging inthyroid associated ophthalmopathy].
Jiang C; Li X; Dend H; Liu J; Huang J; Liu D; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 43(8):869-874. PubMed ID: 30197315
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of 99mTc-DTPA orbital SPECT/CT on the evaluation of lacrimal gland inflammation in patients with
thyroid associated ophthalmopathy].
Jiang C; Li X; Zhao M; Dend H; Huang J; Liu D; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):322-328. PubMed ID: 30971526
[TBL] [Abstract][Full Text] [Related]
5. New Multi-Parameters Combination of Technetium-99m-Diethylene-Triamine-Pentaacetate Orbital Single-Photon Emission Computed Tomography/Computed Tomography for the Evaluation of Graves' Orbitopathy Activity.
Sun L; Peng R; Sun R
Semin Ophthalmol; 2024 Jul; 39(5):387-393. PubMed ID: 38411131
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of
Szumowski P; Abdelrazek S; Żukowski Ł; Mojsak M; Sykała M; Siewko K; Maliszewska K; Popławska-Kita A; Myśliwiec J
BMC Endocr Disord; 2019 Jan; 19(1):10. PubMed ID: 30658624
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves' ophthalmopathy patients.
Liu D; Xu X; Wang S; Jiang C; Li X; Tan J; Deng Z
Int Ophthalmol; 2020 Mar; 40(3):553-561. PubMed ID: 31792849
[TBL] [Abstract][Full Text] [Related]
8.
Sun B; Zhang Z; Dong C; Zhang Y; Yan C; Li S;
Eye (Lond); 2017 May; 31(5):668-676. PubMed ID: 28387769
[TBL] [Abstract][Full Text] [Related]
9. The impact of 99mTc-DTPA orbital SPECT in patient selection for external radiation therapy in Graves' ophthalmopathy.
Szabados L; Nagy EV; Ujhelyi B; Urbancsek H; Varga J; Nagy E; Galuska L
Nucl Med Commun; 2013 Feb; 34(2):108-12. PubMed ID: 23196678
[TBL] [Abstract][Full Text] [Related]
10. Retrobulbar 99mTc-diethylenetriamine-pentaacetic-acid uptake may predict the effectiveness of immunosuppressive therapy in Graves' ophthalmopathy.
Ujhelyi B; Erdei A; Galuska L; Varga J; Szabados L; Balazs E; Bodor M; Cseke B; Karanyi Z; Leovey A; Mezosi E; Burman KD; Berta A; Nagy EV
Thyroid; 2009 Apr; 19(4):375-80. PubMed ID: 19355827
[TBL] [Abstract][Full Text] [Related]
11. Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves' disease.
Burggasser G; Hurtl I; Hauff W; Lukas J; Greifeneder M; Heydari B; Thaler A; Wedrich A; Virgolini I
J Nucl Med; 2003 Oct; 44(10):1547-55. PubMed ID: 14530465
[TBL] [Abstract][Full Text] [Related]
12. Imaging of disease activity in Graves' orbitopathy with different methods: comparison of (99m)Tc-DTPA and (99m)Tc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores.
Galuska L; Leovey A; Szucs-Farkas Z; Szabados L; Garai I; Berta A; Balazs E; Varga J; Nagy EV
Nucl Med Commun; 2005 May; 26(5):407-14. PubMed ID: 15838422
[TBL] [Abstract][Full Text] [Related]
13. 99mTc(V)-DMSA SPECT for the assessment of disease activity in Graves' ophthalmopathy.
Reyhan M; Toygar O; Sukan A; Seydaoglu G; Bakiner OS; Aydin M; Yapar AF; Aktas A
Nucl Med Commun; 2007 Oct; 28(10):775-81. PubMed ID: 17728607
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of autoimmune disease activity in endocrine orbitopathy: comparison of SPECT using 99m-Tc-DTPA or 99m-Tc-depreotide and MRI scores].
Galuska L; Nagy E; Szúcs-Farkas Z; Szabados L; Garai I; Szabó J; Varga J; Leövey A
Orv Hetil; 2003 Oct; 144(41):2017-22. PubMed ID: 14631894
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].
Yang M; Du BX; Wang YJ; He WM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of orbital scintigraphy with 99Tc(m)-octreotide in patients with thyroid associated ophthalmopathy].
Duan L; Li XF; Lu KY; Zhang CG; Hu G; Liu JZ; Li SJ
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1068-72. PubMed ID: 17415962
[TBL] [Abstract][Full Text] [Related]
17. SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MRI.
Galuska L; Leovey A; Szucs-Farkas Z; Garai I; Szabo J; Varga J; Nagy EV
Nucl Med Commun; 2002 Dec; 23(12):1211-6. PubMed ID: 12464787
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and Predicting Treatment Response of Extraocular Muscles in Grave's Orbitopathy by
Jiang C; Deng Z; Huang J; Deng H; Tan J; Li X; Zhao M
Front Med (Lausanne); 2021; 8():791131. PubMed ID: 34977092
[No Abstract] [Full Text] [Related]
19. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
20. [A study on observing the central macular choroidal thickness of thyroid-associated ophthalmopathy patients with spectral-domain optical coherence tomography].
Zhu Y; Song Y; Cai Q; Zhou Y; Li JJ
Zhonghua Yan Ke Za Zhi; 2018 Sep; 54(9):688-693. PubMed ID: 30220185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
